The expression of Wilms' tumour-1 and Ca125 in invasive micropapillary carcinoma of the breast

A. H S Lee, E. C. Paish, C. Marchio, A. Sapino, F. C. Schmitt, I. O. Ellis, J. S. Reis-Filho

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Aim: Metastases from ovarian serous papillary carcinoma to the breast and primary invasive micropapillary carcinoma of the breast are histologically similar. The distinction is clinically important to ensure appropriate management. Wilms' tumour-1 (WT1) and Ca125 are frequently expressed in serous papillary carcinomas, and uncommonly in unselected mammary carcinomas. One previous study found Ca125 expression in 69% of invasive micropapillary carcinomas. The aim was to assess the frequency of expression of WT1 and Ca125 in invasive micropapillary carcinoma. Methods and results: Twenty-five of 34 invasive micropapillary carcinomas showed no nuclear expression of WT1. The remaining nine tumours showed weak to moderate immunoreactivity in 1-10% of nuclei. Six of these nine tumours also contained ductal carcinoma in situ, which expressed WT1 in five of the six. Membranous or cytoplasmic expression of Ca125 was found in seven tumours. Conclusion: Nuclear WT1 expression is present in a minority of invasive micropapillary carcinomas and, when present, expression is focal. The frequency of expression of Ca125 was similar to the results in unselected mammary carcinoma. Thus, these markers are useful members of the immunohistochemical panel for the distinction of mammary invasive micropapillary carcinoma from ovarian serous papillary carcinoma.

Original languageEnglish
Pages (from-to)824-828
Number of pages5
JournalHistopathology
Volume51
Issue number6
DOIs
Publication statusPublished - Dec 2007

Fingerprint

Wilms Tumor
Breast Neoplasms
Papillary Carcinoma
Carcinoma
Breast
Neoplasms
Carcinoma, Intraductal, Noninfiltrating
Neoplasm Metastasis

Keywords

  • Breast
  • Ca125
  • Immunohistochemistry
  • Metastasis
  • Ovary
  • WT1

ASJC Scopus subject areas

  • Anatomy
  • Pathology and Forensic Medicine
  • Cell Biology

Cite this

Lee, A. H. S., Paish, E. C., Marchio, C., Sapino, A., Schmitt, F. C., Ellis, I. O., & Reis-Filho, J. S. (2007). The expression of Wilms' tumour-1 and Ca125 in invasive micropapillary carcinoma of the breast. Histopathology, 51(6), 824-828. https://doi.org/10.1111/j.1365-2559.2007.02884.x

The expression of Wilms' tumour-1 and Ca125 in invasive micropapillary carcinoma of the breast. / Lee, A. H S; Paish, E. C.; Marchio, C.; Sapino, A.; Schmitt, F. C.; Ellis, I. O.; Reis-Filho, J. S.

In: Histopathology, Vol. 51, No. 6, 12.2007, p. 824-828.

Research output: Contribution to journalArticle

Lee, AHS, Paish, EC, Marchio, C, Sapino, A, Schmitt, FC, Ellis, IO & Reis-Filho, JS 2007, 'The expression of Wilms' tumour-1 and Ca125 in invasive micropapillary carcinoma of the breast', Histopathology, vol. 51, no. 6, pp. 824-828. https://doi.org/10.1111/j.1365-2559.2007.02884.x
Lee, A. H S ; Paish, E. C. ; Marchio, C. ; Sapino, A. ; Schmitt, F. C. ; Ellis, I. O. ; Reis-Filho, J. S. / The expression of Wilms' tumour-1 and Ca125 in invasive micropapillary carcinoma of the breast. In: Histopathology. 2007 ; Vol. 51, No. 6. pp. 824-828.
@article{335f2b89c90f47ab97093a7647734a7e,
title = "The expression of Wilms' tumour-1 and Ca125 in invasive micropapillary carcinoma of the breast",
abstract = "Aim: Metastases from ovarian serous papillary carcinoma to the breast and primary invasive micropapillary carcinoma of the breast are histologically similar. The distinction is clinically important to ensure appropriate management. Wilms' tumour-1 (WT1) and Ca125 are frequently expressed in serous papillary carcinomas, and uncommonly in unselected mammary carcinomas. One previous study found Ca125 expression in 69{\%} of invasive micropapillary carcinomas. The aim was to assess the frequency of expression of WT1 and Ca125 in invasive micropapillary carcinoma. Methods and results: Twenty-five of 34 invasive micropapillary carcinomas showed no nuclear expression of WT1. The remaining nine tumours showed weak to moderate immunoreactivity in 1-10{\%} of nuclei. Six of these nine tumours also contained ductal carcinoma in situ, which expressed WT1 in five of the six. Membranous or cytoplasmic expression of Ca125 was found in seven tumours. Conclusion: Nuclear WT1 expression is present in a minority of invasive micropapillary carcinomas and, when present, expression is focal. The frequency of expression of Ca125 was similar to the results in unselected mammary carcinoma. Thus, these markers are useful members of the immunohistochemical panel for the distinction of mammary invasive micropapillary carcinoma from ovarian serous papillary carcinoma.",
keywords = "Breast, Ca125, Immunohistochemistry, Metastasis, Ovary, WT1",
author = "Lee, {A. H S} and Paish, {E. C.} and C. Marchio and A. Sapino and Schmitt, {F. C.} and Ellis, {I. O.} and Reis-Filho, {J. S.}",
year = "2007",
month = "12",
doi = "10.1111/j.1365-2559.2007.02884.x",
language = "English",
volume = "51",
pages = "824--828",
journal = "Histopathology",
issn = "0309-0167",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - The expression of Wilms' tumour-1 and Ca125 in invasive micropapillary carcinoma of the breast

AU - Lee, A. H S

AU - Paish, E. C.

AU - Marchio, C.

AU - Sapino, A.

AU - Schmitt, F. C.

AU - Ellis, I. O.

AU - Reis-Filho, J. S.

PY - 2007/12

Y1 - 2007/12

N2 - Aim: Metastases from ovarian serous papillary carcinoma to the breast and primary invasive micropapillary carcinoma of the breast are histologically similar. The distinction is clinically important to ensure appropriate management. Wilms' tumour-1 (WT1) and Ca125 are frequently expressed in serous papillary carcinomas, and uncommonly in unselected mammary carcinomas. One previous study found Ca125 expression in 69% of invasive micropapillary carcinomas. The aim was to assess the frequency of expression of WT1 and Ca125 in invasive micropapillary carcinoma. Methods and results: Twenty-five of 34 invasive micropapillary carcinomas showed no nuclear expression of WT1. The remaining nine tumours showed weak to moderate immunoreactivity in 1-10% of nuclei. Six of these nine tumours also contained ductal carcinoma in situ, which expressed WT1 in five of the six. Membranous or cytoplasmic expression of Ca125 was found in seven tumours. Conclusion: Nuclear WT1 expression is present in a minority of invasive micropapillary carcinomas and, when present, expression is focal. The frequency of expression of Ca125 was similar to the results in unselected mammary carcinoma. Thus, these markers are useful members of the immunohistochemical panel for the distinction of mammary invasive micropapillary carcinoma from ovarian serous papillary carcinoma.

AB - Aim: Metastases from ovarian serous papillary carcinoma to the breast and primary invasive micropapillary carcinoma of the breast are histologically similar. The distinction is clinically important to ensure appropriate management. Wilms' tumour-1 (WT1) and Ca125 are frequently expressed in serous papillary carcinomas, and uncommonly in unselected mammary carcinomas. One previous study found Ca125 expression in 69% of invasive micropapillary carcinomas. The aim was to assess the frequency of expression of WT1 and Ca125 in invasive micropapillary carcinoma. Methods and results: Twenty-five of 34 invasive micropapillary carcinomas showed no nuclear expression of WT1. The remaining nine tumours showed weak to moderate immunoreactivity in 1-10% of nuclei. Six of these nine tumours also contained ductal carcinoma in situ, which expressed WT1 in five of the six. Membranous or cytoplasmic expression of Ca125 was found in seven tumours. Conclusion: Nuclear WT1 expression is present in a minority of invasive micropapillary carcinomas and, when present, expression is focal. The frequency of expression of Ca125 was similar to the results in unselected mammary carcinoma. Thus, these markers are useful members of the immunohistochemical panel for the distinction of mammary invasive micropapillary carcinoma from ovarian serous papillary carcinoma.

KW - Breast

KW - Ca125

KW - Immunohistochemistry

KW - Metastasis

KW - Ovary

KW - WT1

UR - http://www.scopus.com/inward/record.url?scp=36549051580&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36549051580&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2559.2007.02884.x

DO - 10.1111/j.1365-2559.2007.02884.x

M3 - Article

VL - 51

SP - 824

EP - 828

JO - Histopathology

JF - Histopathology

SN - 0309-0167

IS - 6

ER -